Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    Immunovative
Show Display Options
Rank Status Study
1 Completed In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Condition: Metastatic Cancer
Interventions: Biological: AlloStim-7;   Procedure: percutaneous tumor cryoablation;   Biological: AlloStim8 or AlloStim-9
2 Not yet recruiting AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Biological: AlloStim®;   Procedure: cryoablation;   Other: Physician's Choice (PC)
3 Withdrawn Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match Alternative to Allogeneic Transplant for Blood Cancers
Condition: Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma
Intervention: Biological: AlloStim-8
4 Withdrawn Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer
Conditions: Solid Tumors Stage II, Stage III and Stage IV;   Breast Cancer;   Colorectal Cancer;   Prostate Cancer;   Melanoma;   Ovarian Cancer;   Sarcoma;   Non-small Cell Lung Cancer
Interventions: Biological: AlloStim;   Procedure: Cryoablation
5 Completed A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy
Conditions: Hematological Malignancy;   Leukemia;   Lymphoma;   Multiple Myeloma
Intervention: Biological: AlloStim
6 Withdrawn Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients
Condition: Metastatic Breast Cancer
Interventions: Biological: AlloStim;   Procedure: Cryoablation
7 Active, not recruiting Safety and Tolerability Study of AlloVax(TM) in Patients With Metastatic or Recurrent Cancer of the Head and Neck
Conditions: Cancer of Head and Neck;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: AlloVax;   Biological: CRCL;   Biological: AlloStim;   Other: PlasmaLyteA with 1% human serum albumin
8 Withdrawn In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer
Condition: Hepatocellular Carcinoma
Intervention: Biological: AlloStim
9 Recruiting Increased Frequency of AlloStim® Immunotherapy Dosing in Combination With Cryoablation in Metastatic Colorectal Cancer
Condition: Colorectal Cancer Metastatic
Interventions: Biological: AlloStim;   Procedure: Cryoablation
10 Not yet recruiting Study Comparing AlloVax™ to Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck
Condition: Squamous Cell Carcinoma Head and Neck
Interventions: Biological: AlloVax™;   Drug: Cisplatin
11 Recruiting An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects
Condition: Advanced Adult Hepatocellular Carcinoma
Interventions: Biological: AlloVax;   Biological: AlloStim;   Biological: CRCL
12 Withdrawn An Individualized Anti-Cancer Vaccine Study in Patients With HCC
Condition: Hepatocellular Carcinoma
Interventions: Biological: AlloVax;   Biological: CRCL;   Biological: AlloStim

Study has passed its completion date and status has not been verified in more than two years.